Survivin expression predicts poor outcome in malignant lymphoma.

被引：0
|
作者：
Depowski, PL [1 ]
Graber, MW [1 ]
Purdy, S [1 ]
Ross, JS [1 ]
Nazeer, T [1 ]
机构：
[1] Albany Med Coll, Albany, NY 12208 USA
来源：
LABORATORY INVESTIGATION | 2001年 / 81卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
941
引用
收藏
页码：161A / 161A
页数：1
相关论文
共 50 条
  • [31] Survivin mRNA expression is elevated in malignant urothelial cell carcinomas and predicts time to recurrence
    Schultz, IJ
    Kiemeney, LA
    Witjes, JA
    Schalken, JA
    Willems, JL
    Swinkels, DW
    De Kok, JB
    ANTICANCER RESEARCH, 2003, 23 (04) : 3327 - 3331
  • [32] Classification of malignant lymphoma. WHO international proposal
    Diebold, J
    ANNALES DE PATHOLOGIE, 1998, 18 (04) : 361 - 367
  • [33] Recommendations for revised response criteria for malignant lymphoma.
    Cheson, B. D.
    Pfistner, B.
    Juweid, M. E.
    Horning, S. J.
    Coiffier, B.
    Gascoyne, R. D.
    Fisher, R. I.
    Hagenbeek, A.
    Hoppe, R. T.
    Diehl, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 423S - 423S
  • [34] Education needs assessment of patients with malignant lymphoma.
    Piliotis, E
    Vakani, S
    Vlosak, D
    Imrie, K
    BLOOD, 2003, 102 (11) : 506B - 506B
  • [35] Hypercalcaemia and malignant lymphoma. One case report
    Frein, D.
    Lavigne, C.
    Josselin, N.
    Foussard, C.
    Sivova, N.
    Moles, M. P.
    Berrut, G.
    REVUE DE MEDECINE INTERNE, 2007, 28 (10): : 714 - 715
  • [36] Paraneoplastic acquired ichtyosis revealing malignant lymphoma.
    Estines, O
    Grosieux-Dauger, C
    Derancourt, C
    Patey, M
    Durlach, A
    Bernard, P
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2001, 128 (01): : 31 - 34
  • [37] Thymus phenomenon in chemotherapy of children with malignant lymphoma.
    Arabadjieva, D
    Belcheva, M
    Kaleva, V
    Kertikova, S
    Sheytanova, E
    Balev, B
    Kovachev, S
    ANNALS OF ONCOLOGY, 2000, 11 : 105 - 105
  • [38] Reduced or absent cyclin dependant kinase (CAK) expression is an independent prognostic marker for poor outcome in diffuse large B cell lymphoma.
    Bavi, Prashant
    Devarajan, Sriraman
    Atizado, Valerie
    Balde, Valorie
    Siddiqui, Shakaib
    Moorji, Azad
    Al-Dossary, Hassan
    Ezzat, Adnan
    Al-Dayel, Fouad
    Uddin, Shahab
    Al-Kuraya, Khawla
    CANCER RESEARCH, 2008, 68 (09)
  • [39] Autologous bone marrow and/or peripheral blood stem cells transplantation in patients with poor risk malignant lymphoma.
    Minigo, H
    Planinc-Peraica, A
    Kardum-Skelin, I
    Sustercic, D
    Ostojic, S
    Radic-Kristo, D
    Siftar, Z
    Strauss-Patko, M
    Maglov, C
    Jaksic, B
    BONE MARROW TRANSPLANTATION, 1998, 21 : S171 - S171
  • [40] Immunophenotype predicts rearrangement of cMYC in adult Burkitt lymphoma.
    Barrans, SL
    O'Connor, SJM
    Jane, KS
    Turner, K
    Owen, RG
    Gareth, MJ
    Jack, A
    BLOOD, 2002, 100 (11) : 351A - 352A
12345